Choisissez la langue de votre document :
- bg - български
- es - español
- cs - čeština
- da - dansk
- de - Deutsch
- et - eesti keel
- el - ελληνικά
- en - English (výběr)
- fr - français
- ga - Gaeilge
- hr - hrvatski
- it - italiano
- lv - latviešu valoda
- lt - lietuvių kalba
- hu - magyar
- mt - Malti
- nl - Nederlands
- pl - polski
- pt - português
- ro - română
- sk - slovenčina
- sl - slovenščina
- fi - suomi
- sv - svenska
 |
| Parliamentary questions |
| |||
| 28 August 2018 |
| |||
| Question for written answer E-004360-18 to the Commission Rule 130 Rory Palmer (S&D) | ||||
 Subject: Myalgic encephalomyelitis: recognition by the World Health Organisation and Commission support for research and training |
| ||
|
Will the Commission make formal representations to the World Health Organisation (WHO) in support of the WHO officially recognising myalgic encephalomyelitis (ME) as a ‘serious, chronic, complex and multisystem disease that frequently and dramatically limits the activities of affected patients’ (as defined by the Institute of Medicine in 2015)? Furthermore, will the Commission support further and accelerated biomedical research to develop improved diagnostic methods and treatments for ME? Will the Commission undertake to support efforts to ensure appropriate and improved medical education and training for health and social care professionals working with ME patients? | |||
| Poslední aktualizace: 12. září 2018 | Právní upozornění - Ochrana soukromí |